Siemens Healthineers AG (OTCMKTS:SMMNY) Receives Consensus Rating of “Buy” from Brokerages

Posted by Trevor Kearing on Jan 12th, 2026

Shares of Siemens Healthineers AG (OTCMKTS:SMMNY – Get Free Report) have received an average rating of “Buy” from the seven ratings firms that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, two have issued a buy recommendation and three have given a strong buy recommendation to the company.

Several equities research analysts recently weighed in on the stock. Royal Bank Of Canada started coverage on shares of Siemens Healthineers in a research report on Wednesday, December 17th. They issued a “moderate buy” rating on the stock. Zacks Research downgraded shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a report on Friday, December 12th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Siemens Healthineers from a “buy” rating to a “hold” rating in a report on Thursday, December 4th.

View Our Latest Research Report on Siemens Healthineers

Siemens Healthineers Stock Up 1.2%

OTCMKTS:SMMNY opened at $27.36 on Friday. Siemens Healthineers has a 1 year low of $23.28 and a 1 year high of $30.19. The stock’s 50 day simple moving average is $25.57 and its two-hundred day simple moving average is $26.85.

Siemens Healthineers Company Profile

(Get Free Report)

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.